Caplin Point Lab

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE475E01026
  • NSEID: CAPLIPOINT
  • BSEID: 524742
INR
2,028.80
-56.6 (-2.71%)
BSENSE

Nov 20

BSE+NSE Vol: 1.9 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 640544,
    "name": "Caplin Point Lab",
    "stock_name": "Caplin Point Lab",
    "full_name": "Caplin Point Laboratories Ltd",
    "name_url": "stocks-analysis/caplin-point-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,028.80",
    "chg": -56.6,
    "chgp": "-2.71%",
    "dir": -1,
    "prev_price": "2,085.40",
    "mcapval": "15,611.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524742,
    "symbol": "CAPLIPOINT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE475E01026",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.9 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/caplin-point-lab-640544-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Caplin Point Laboratories Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-hold-4269108",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/CaplinPointLabo_mojoScore_4269108.png",
        "date": "2026-11-20 10:11:09",
        "description": "Caplin Point Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-intraday-low-amid-price-pressure-4266936",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/CaplinPointLabo_priceRelatedfactors_4266936.png",
        "date": "2026-11-18 10:22:35",
        "description": "Caplin Point Laboratories Ltd experienced a significant intraday decline on 18 Nov 2026, touching a low of Rs 2,073.5, down 7.89% from the previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and heightened volatility."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-hold-4256656",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/CaplinPointLabo_mojoScore_4256656.png",
        "date": "2026-11-09 10:10:40",
        "description": "Caplin Point Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-hold-4241865",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CaplinPointLabo_mojoScore_4241865.png",
        "date": "2026-10-28 10:10:44",
        "description": "Caplin Point Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4240026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CaplinPointLabo_technicaldot_4240026.png",
        "date": "2026-10-27 08:03:47",
        "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and relative performance against the Sensex suggest cautious optimism among investors."
      },
      {
        "title": "Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/caplin-point-laboratories-ltd-sees-technical-momentum-shift-amid-mixed-signals-4232861",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CaplinPointLabo_technicaldot_4232861.png",
        "date": "2026-10-22 08:03:56",
        "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a cautious outlook for investors amid recent price fluctuations."
      },
      {
        "title": "Caplin Point Laboratories Ltd: Technical Momentum Shifts Signal Cautious Outlook",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-signal-cautious-outlook-4231358",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CaplinPointLabo_technicaldot_4231358.png",
        "date": "2026-10-21 08:04:50",
        "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s long-term returns continue to outperform the Sensex, underscoring its resilience amid market volatility."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-hold-4228455",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CaplinPointLabo_mojoScore_4228455.png",
        "date": "2026-10-17 10:10:05",
        "description": "Caplin Point Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 October 2026, providing investors with the latest insights into the company's performance and outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/caplin-point-laboratories-ltd-faces-technical-momentum-shift-amid-mixed-indicator-signals-4224826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CaplinPointLabo_technicaldot_4224826.png",
        "date": "2026-10-14 08:04:04",
        "description": "Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of mid-October 2026. Despite a strong year-to-date return of 28.3%, the stock’s recent price action and technical indicators suggest a period of consolidation and caution for investors in the pharmaceuticals and biotechnology sector."
      }
    ],
    "total": 93,
    "sid": "640544",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/caplin-point-laboratories-640544"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "19-Nov-2026",
      "details": "Transcript for Earnings call - Q2 - FY 2026-27",
      "source": "BSE"
    },
    {
      "caption": "Update On US FDA Inspection At The Facility Of Caplin Steriles Limited Subsidiary Of The Company",
      "datetime": "17-Nov-2026",
      "details": " Classification of US FDA Inspection at the facility of Caplin Steriles Limited subsidiary of the Company as OAI",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Meeting Held On November 12 2026",
      "datetime": "12-Nov-2026",
      "details": "Board Meeting Outcome for Meeting Held on November 12 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 18 Sep 26",
          "dt": "2026-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16",
          "dt": "2016-10-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

19-Nov-2026 | Source : BSE

Transcript for Earnings call - Q2 - FY 2026-27

Update On US FDA Inspection At The Facility Of Caplin Steriles Limited Subsidiary Of The Company

17-Nov-2026 | Source : BSE

Classification of US FDA Inspection at the facility of Caplin Steriles Limited subsidiary of the Company as OAI

Board Meeting Outcome for Meeting Held On November 12 2026

12-Nov-2026 | Source : BSE

Board Meeting Outcome for Meeting Held on November 12 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Caplin Point Laboratories Ltd has declared 200% dividend, ex-date: 18 Sep 26

stock-summary
SPLITS

Caplin Point Laboratories Ltd has announced 2:10 stock split, ex-date: 19 Oct 16

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available